Free Trial

Glanbia (OTCMKTS:GLAPY) Trading Down 1.2% - Here's Why

Glanbia logo with Consumer Staples background

Key Points

  • Glanbia's share price decreased by 1.2% to $80.95, with trading volume plummeting to just 3 shares compared to an average of 37 shares.
  • The company announced a dividend of $0.9751 per share with a remarkably high dividend yield of 272.0%, set to be paid on October 14th.
  • Glanbia plc operates as a nutrition company, offering a variety of products, including sports nutrition, dairy, and vitamin supplements globally.
  • MarketBeat previews the top five stocks to own by October 1st.

Glanbia Plc ADR (OTCMKTS:GLAPY - Get Free Report) fell 1.2% during trading on Thursday . The stock traded as low as $80.95 and last traded at $80.95. 3 shares changed hands during mid-day trading, a decline of 92% from the average session volume of 37 shares. The stock had previously closed at $81.96.

Glanbia Price Performance

The company has a current ratio of 1.41, a quick ratio of 0.81 and a debt-to-equity ratio of 0.31. The business has a fifty day moving average price of $75.35 and a 200 day moving average price of $69.68.

Glanbia Cuts Dividend

The business also recently announced a dividend, which will be paid on Tuesday, October 14th. Investors of record on Tuesday, August 26th will be paid a dividend of $0.9751 per share. This represents a yield of 272.0%. The ex-dividend date is Monday, August 25th.

Glanbia Company Profile

(Get Free Report)

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products.

Featured Articles

Should You Invest $1,000 in Glanbia Right Now?

Before you consider Glanbia, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Glanbia wasn't on the list.

While Glanbia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.